What should I do if myasthenia gravis is accompanied by a fever?

Written by Zhang Hui
Neurology
Updated on February 15, 2025
00:00
00:00

Patients with myasthenia gravis are most afraid of developing a fever, as a fever may indicate an infection, especially a bacterial infection. If a bacterial infection occurs, it can easily trigger a myasthenic crisis. The patient may experience weakness in breathing and even respiratory failure, which can be life-threatening. Therefore, it is essential to address the situation promptly. The recommended approach when a fever occurs is as follows: First, quickly determine the cause of the fever, complete routine blood tests, calcitonin, and other relevant assays to confirm if it is caused by a bacterial infection. Second, symptomatically manage the fever, possibly using antipyretic medications. Third, if it is a bacterial infection, it is crucial to promptly administer a significant amount of effective antibiotics to treat it. Controlling the bacterial infection can prevent the progression of myasthenia gravis to a more severe state. (Note: Medication should be used under the guidance of a doctor.)

Other Voices

doctor image
home-news-image
Written by Zhang Hui
Neurology
1min 12sec home-news-image

Myasthenia Gravis Test Items

Myasthenia gravis is a common neurological disease, primarily an autoimmune disorder. It typically results in symptoms that are worse in the evening and fluctuate throughout the day, mainly manifesting as limb weakness, double vision, swallowing difficulties, and speech impairments. In severe cases, it can even affect respiration, leading to weakness of the respiratory muscles and necessitating the assistance of a ventilator. The key examinations for myasthenia gravis include: Firstly, a chest CT scan. Many patients with myasthenia gravis have thymic hyperplasia or thymomas, making this scan crucial. Secondly, repetitive nerve stimulation electromyography. This test can detect amplitude decrement in response to stimulation, which is significant for diagnosing the disease. Thirdly, testing for specific antibodies related to myasthenia gravis, such as acetylcholine receptor antibodies. The presence of these antibodies is very important for diagnosis. Additionally, other tests such as erythrocyte sedimentation rate and thyroid function tests are also conducted.

doctor image
home-news-image
Written by Zhang Hui
Neurology
1min 7sec home-news-image

incidence of myasthenia gravis

Myasthenia gravis is a disease of the neurology department. Its incidence rate is around one in one hundred thousand. The prevalence rate is around fifty per one hundred thousand. In China, the incidence rate in the south is slightly higher than in the north. This is an autoimmune disease of the nervous system. Generally, it is due to the production of some abnormal antibodies. These antibodies cause dysfunction in synaptic transmission at the neuromuscular junction, leading to corresponding clinical manifestations in patients. For example, extreme fatigue after physical activity that can only be alleviated by rest. Patients may also exhibit clinical symptoms such as ptosis, diplopia, and difficulty swallowing, and in severe cases, even respiratory muscle weakness may occur, requiring the use of a ventilator. This disease can occur at any age, affecting children as well as elderly men aged 70 to 80. Therefore, correct understanding of this disease and timely treatment are very important.

doctor image
home-news-image
Written by Zhang Hui
Neurology
55sec home-news-image

Can myasthenia gravis be cured?

Myasthenia gravis is a type of disease in the field of neurology and is categorized as an autoimmune disorder of the nervous system. Generally, this disease tends to recur easily, and it is somewhat difficult to cure completely. However, there is a subtype called ocular myasthenia gravis, where patients only show symptoms of eyelid drooping or double vision. In this type, some patients can be cured, typically around 30%. However, most patients still experience recurrent episodes, and the condition may even progress to a generalized form. Other forms of myasthenia gravis are usually more severe, involving generalized weakness and potentially difficulties in swallowing or choking on liquids. Patients with these symptoms should seek medical attention promptly and can be treated with immunosuppressants and acetylcholinesterase inhibitors to control the symptoms, though long-term medication is generally required.

doctor image
home-news-image
Written by Zhang Hui
Neurology
1min 16sec home-news-image

How to alleviate myasthenia gravis?

Myasthenia gravis is a disease of the department of neurology and its incidence is not low, it is also relatively common clinically. The treatment of myasthenia gravis mainly includes the following points: First, if patients with myasthenia gravis also have a thymoma, it is recommended to surgically remove the thymoma as soon as possible, which can significantly alleviate the symptoms of myasthenia gravis and reduce the amount of medication needed. Second, provide patients with some medication, mainly some drugs that suppress the immune response, including some corticosteroids. The use of corticosteroids is relatively complex, and must be gradually increased or decreased under the advice of a doctor. Do not stop taking them on your own. There are also some drugs that are cholinesterase inhibitors, which can increase the content of acetylcholine in the synaptic gap, alleviating the patient's symptoms. In addition, research has confirmed that some new immunosuppressive agents can also be used in the treatment of myasthenia gravis. In summary, the treatment of myasthenia gravis is a comprehensive subject and must be tailored according to the patient's condition.

doctor image
home-news-image
Written by Tang Bo
Neurology
1min 10sec home-news-image

myasthenia gravis-related antibodies

Most cases of myasthenia gravis are mediated by acetylcholine receptor antibodies, involving cell-mediated immunity with complement, generally affecting the neuromuscular junction and causing a neuromuscular transmission disorder. This results in an acquired autoimmune disease of muscle weakness. However, a small number of patients with myasthenia gravis are mediated by muscle-specific kinase antibodies or low-density lipoprotein receptor-related protein 4 antibodies. Its main clinical manifestations include skeletal muscle weakness, fatigue, worsening with activity, and significant alleviation or reduction of symptoms after rest and the use of acetylcholinesterase inhibitors. Additionally, the disease can occur at any age, with females being more affected than males before the age of 40. Between 40 and 50 years old, the incidence rates between males and females are comparable, but after 50 years of age, the incidence rate in males is higher than in females.